Skip to main content

Table 1 Annual consumption of erythropoietin and intravenous iron according Paricalcitol and Calcitriol therapies

From: Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital

Parameter

Paricalcitol

Calcitriol

P-value

Erythropoietin Weekly Average Consumption

11,758 UI

13,930 UI

<0.05

Intravenous Iron Weekly Average Consumption

59 mg

45 mg

<0.05

  1. Source: Capuano, A., 2009
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us